UBS maintains Buy on FactSet Research Systems, lowers target to $340

0 min read | Published on 02 Jul 2026, 08:47 PM |Updated on 02 Jul 2026, 08:47 PM

Reviewed by

Radhika SScanX News Team

Key Highlights

UBS analyst Alex Kramm maintained a Buy rating on FactSet Research Systems and lowered the price target from $380 to $340.

*this image is generated using AI for illustrative purposes only.

UBS analyst Alex Kramm has maintained a Buy rating for FactSet Research Systems while adjusting the valuation outlook. The firm lowered the price target to $340, down from the previous $380. FactSet Research Systems is listed on the NYSE under the ticker symbol FDS. The revision reflects an updated assessment of the company's stock potential despite the positive recommendation.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What factors drove UBS to lower the price target despite maintaining a Buy rating?

How might this revised valuation impact investor sentiment toward FactSet in the short term?

Could this adjustment signal broader challenges in the financial data and analytics sector?

Wolfe Research raises FactSet target to $240, maintains Underperform

1 min read | Published on 02 Jul 2026, 04:44 PM |Updated on 02 Jul 2026, 07:40 PM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

Key Highlights

Wolfe Research analyst Scott Wurtzel maintained an Underperform rating on FactSet Research Systems, raising the price target to $240 from $225. This move reflects a broader trend of valuation updates, with BMO Capital, Morgan Stanley, Wells Fargo, and Evercore ISI Group also adjusting price targets upward.

*this image is generated using AI for illustrative purposes only.

Wolfe Research analyst Scott Wurtzel has maintained an Underperform rating on FactSet Research Systems while raising the price target to $240 from $225. This adjustment aligns with a broader trend of valuation updates across the financial data and analytics sector. FactSet Research Systems trades on the NYSE under the ticker symbol FDS.

Rating and Target Revisions

Research notes from multiple firms have adjusted price objectives upward for the company. The revisions come despite differing stances on the stock's near-term performance potential.

Firm	Rating	Previous Price Target	New Price Target
BMO Capital	Market Perform	$257	$275
Morgan Stanley	Equal-Weight	$228	$230
Wells Fargo	Underweight	$200	$210
Evercore ISI Group	In-Line	$265	$275
Wolfe Research	Underperform	$225	$240

Morgan Stanley analyst Toni Kaplan maintained an Equal-Weight rating with a target increase to $230 from $228. Separately, Wells Fargo analyst Jason Haas kept an Underweight rating but raised the price objective to $210 from $200. BMO Capital analyst Jeffrey Silber maintained a Market Perform rating while raising the price target to $275 from $257. Evercore ISI Group analyst David Motemeden also maintained an In-Line rating while raising the price target to $275 from $265.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What factors are driving the sector-wide valuation updates despite differing stances on near-term performance?

How might FactSet's competitive positioning evolve in response to these analyst adjustments?

What potential market shifts could prompt further revisions to price targets in the financial data sector?